Download PDF
1 / Pages

Other users also viewed these articles

Diagnostic performance of three non-invasive fibrosis scores (Hepamet, FIB-4, NAFLD fibrosis score) in NAFLD patients from a mixed Latin American population Rommel Zambrano-Huailla; Laura Guedes; Jose Tadeu Stefano; Arthur A. Arrais de Souza; Sebastián Marciano; Erika Yvamoto; Matheus Truccolo Michalczuk; Denise Siqueira Vanni; Hernan Rodriguez; Flair Jose Carrilho; Mario Reis Alvares-da-Silva; Adrian Gadano; Marco Arrese; Adelina Lozano Miranda; Claudia P. Oliveira;
Ann Hepatol. 2020;19:622-6
Validation of the Hepamet fibrosis score in a multi-ethnic Asian population Shi-En Chong; Felicia Chang; Kee-Huat Chuah; Pavai Sthaneshwar; Nik Raihan Nik Mustapha; Sanjiv Mahadeva; Wah-Kheong Chan;
Ann Hepatol. 2023;28:
Oral 24-week probiotics supplementation did not decrease cardiovascular risk markers in patients with biopsy proven NASH: A double-blind placebo-controlled randomized study Samantha Thifani Alrutz Barcelos; Amanda Souza Silva-Sperb; Helena Abadie Moraes; Larisse Longo; Bruna Concheski de Moura; Matheus Truccolo Michalczuk; Carolina Uribe-Cruz; Carlos Thadeu Schmidt Cerski; Themis Reverbel da Silveira; Valesca Dall'Alba; Mário Reis Álvares-da-Silva;
Ann Hepatol. 2023;28: